Clinical Edge Journal Scan

COVID-19: Pulmonary embolism not tied to increased mortality risk


 

Key clinical point: Presence of pulmonary embolism (PE) is not associated with increased mortality in patients with COVID-19 risk.

Major finding: Risk factors for PE in patients with COVID-19 included male sex, mechanical ventilation, intensive care unit admission, and circulating D-dimer. Patients with PE did not have an increased risk for mortality compared with those without PE (odds ratio, 1.31; P = .25).

Study details: The data come from a meta-analysis of 16 cohort studies involving 5,826 patients with COVID-19.

Disclosures: No funding information was available. The authors declared no conflict of interests.

Source: Gómez CA et al. Sci Rep. 2021 Aug 6. doi: 10.1038/s41598-021-95512-7 .

Recommended Reading

When children and teens with cancer get COVID-19
Covid ICYMI
Ten lessons learned from the pandemic, and a way forward: Report
Covid ICYMI
Pandemic restrictions ignite innovative pivot for psychiatry
Covid ICYMI
Remdesivir sharply cuts COVID hospitalization risk, Gilead says
Covid ICYMI
Age, C-reactive protein predict COVID-19 death in diabetes
Covid ICYMI
Worsening motor function tied to post COVID syndrome in Parkinson’s disease
Covid ICYMI
SARS-CoV-2 Delta variant may double the risk for hospitalization
Covid ICYMI
Lower risk for COVID-19 in patients with asthma
Covid ICYMI
Baricitinib plus standard of care may reduce mortality risk in hospitalized patients with COVID-19
Covid ICYMI
COVID-19: Early administration of plasma fails to prevent disease progression
Covid ICYMI